Patents by Inventor Philip Wallace

Philip Wallace has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CTLA4 molecules and IL4-binding molecules and uses thereof
    Publication number: 20080031876
    Abstract: The invention identifies the CTLA4 receptor as a ligand for the B7 antigen. The complete amino acid sequence encoding human CTLA4 receptor gene is provided. Methods are provided for expressing CTLA4 as an immunoglobulin fusion protein, for preparing hybrid CTLA4 fusion proteins, and for using the soluble fusion proteins, fragments and derivatives thereof, including monoclonal antibodies reactive with B7 and CTLA4, to regulate T cell interactions and immune responses mediated by such interactions.
    Type: Application
    Filed: March 19, 2007
    Publication date: February 7, 2008
    Applicant: Bristol-Myers Squibb Company
    Inventors: Peter Linsley, Jeffrey Ledbetter, Nitin Damle, William Brady, Philip Wallace
  • Soluble CTLA4 mutant molecules and uses thereof
    Patent number: 7105166
    Abstract: The present invention provides soluble CTLA4 mutant molecules which bind CD80 and/or CD86 antigen.
    Type: Grant
    Filed: July 3, 2000
    Date of Patent: September 12, 2006
    Assignee: Bristol-Myers Squibb Company
    Inventors: Peter S. Linsley, Jeffrey A. Ledbetter, Jurgen Bajorath, Robert J. Peach, William Brady, Philip Wallace, Nitin Damle